Pelthos Therapeutics Inc.
PTHS
$25.70
$0.562.23%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.41M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.41M | -- | -- | -- | -- |
| Cost of Revenue | 2.28M | 229.90K | -271.90K | 400.00 | 609.40K |
| Gross Profit | 5.13M | -229.90K | 271.90K | -400.00 | -609.40K |
| SG&A Expenses | 25.52M | 7.53M | 6.56M | 6.39M | 6.44M |
| Depreciation & Amortization | 679.00K | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.66M | 8.94M | 7.47M | 7.57M | 9.63M |
| Operating Income | -22.25M | -8.94M | -7.47M | -7.57M | -9.63M |
| Income Before Tax | -24.05M | -9.04M | -7.36M | -7.96M | -10.07M |
| Income Tax Expenses | -465.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.58 | -9.04 | -7.36 | -7.96 | -10.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.58M | -9.04M | -7.36M | -7.96M | -10.07M |
| EBIT | -22.25M | -8.94M | -7.47M | -7.57M | -9.63M |
| EBITDA | -15.01M | -- | -- | -- | -- |
| EPS Basic | -17.09 | -14.71 | -12.40 | -14.65 | -31.56 |
| Normalized Basic EPS | -10.78 | -9.20 | -7.75 | -9.16 | -19.73 |
| EPS Diluted | -17.09 | -14.71 | -12.40 | -14.65 | -31.56 |
| Normalized Diluted EPS | -10.78 | -9.20 | -7.75 | -9.16 | -19.73 |
| Average Basic Shares Outstanding | 4.92M | 2.44M | 2.37M | 2.23M | 1.83M |
| Average Diluted Shares Outstanding | 4.92M | 2.44M | 2.37M | 2.23M | 1.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |